UPPI to partner with Telix on development of new Prostate Cancer Imaging Agent
Telix Pharmaceuticals Limited (ASX: TLX) is a global biopharmaceutical company based in Melbourne. The company develops...
Read More
Amyloid PET changed clinical management in 60% of patients with dementia
Amyloid PET imaging greatly influenced the clinical management of patients with mild cognitive impairment (MCI)...
Read More